Reduced expression or mutations in LLGL1 (also known as HUGL1), are associated with hepatocellular carcinoma (Lu et al., 2009), malignant melanoma (Kuphal et al., 2006) and colorectal cancer (Schimanski et al., 2005). Here, LLGL1 is linked to colorectal cancer.